| View |
DR-XY46369_PI_01.pdf
|
DR-XY46369
|
Brexpiprazole
|
Rexulti
|
500mcg
|
Tablet
|
Anti-psychotic
|
Otsuka Pharmaceutical Co. Ltd. (Tokushima Factory)
|
Japan
|
Monitored Release
|
08 June 2018
|
08 June 2025
|
| View |
DR-XY46370_PI_01.pdf
|
DR-XY46370
|
Brexpiprazole
|
Rexulti
|
1mg
|
Tablet
|
Anti-psychotic
|
Otsuka Pharmaceutical Co. Ltd. (Tokushima Factory)
|
Japan
|
Monitored Release
|
08 June 2018
|
08 June 2025
|
| View |
DR-XY46371_PI_01.pdf
|
DR-XY46371
|
Brexpiprazole
|
Rexulti
|
2mg
|
Tablet
|
Anti-psychotic
|
Otsuka Pharmaceutical Co. Ltd. (Tokushima Factory)
|
Japan
|
Monitored Release
|
08 June 2018
|
08 June 2025
|
| View |
DR-XY46372_PI_01.pdf
|
DR-XY46372
|
Brexpiprazole
|
Rexulti
|
3mg
|
Tablet
|
Anti-psychotic
|
Otsuka Pharmaceutical Co. Ltd. (Tokushima Factory)
|
Japan
|
Monitored Release
|
08 June 2018
|
08 June 2025
|
| View |
DR-XY46373_PI_01.pdf
|
DR-XY46373
|
Brexpiprazole
|
Rexulti
|
4mg
|
Tablet
|
Anti-psychotic
|
Otsuka Pharmaceutical Co. Ltd. (Tokushima Factory)
|
Japan
|
Monitored Release
|
08 June 2018
|
08 June 2025
|
| View |
DR-XY46374_PI_01.pdf
|
DR-XY46374
|
Atorvastatin + Perindopril (as arginine) + Amlodipine
|
Triveram Forte
|
40mg/ 10mg/ 10mg
|
Film-Coated Tablet
|
Antihypertensive/Anti-CAD/Antihyperlipidemic
|
Les Laboratoires Servier Industrie
|
France
|
Monitored Release
|
02 December 2019
|
11 June 2025
|
| View |
DR-XY46375_PI_01.pdf
|
DR-XY46375
|
Atorvastatin + Perindopril (as arginine) + Amlodipine
|
Triveram
|
20mg/ 10mg/ 10mg
|
Film-Coated Tablet
|
Antihypertensive/Anti-CAD/Antihyperlipidemic
|
Les Laboratoires Servier Industrie
|
France
|
Monitored Release
|
11 June 2018
|
11 June 2025
|
| View |
DR-XY46376_PI_01.pdf
|
DR-XY46376
|
Atorvastatin + Perindopril (as arginine) + Amlodipine
|
Triveram
|
20mg/ 10mg/ 5mg
|
Film-Coated Tablet
|
Antihypertensive/Anti-CAD/Antihyperlipidemic
|
Les Laboratoires Servier Industrie
|
France
|
Monitored Release
|
11 June 2018
|
11 June 2025
|
| View |
DR-XY46377_PI_01.pdf
|
DR-XY46377
|
Atorvastatin + Perindopril (as arginine) + Amlodipine
|
Triveram
|
20mg/ 5mg/ 5mg
|
Film-Coated Tablet
|
Antihypertensive/Anti-CAD/Antihyperlipidemic
|
Les Laboratoires Servier Industrie
|
France
|
Monitored Release
|
02 December 2019
|
11 June 2025
|
| View |
DR-XY46378_PI_01.pdf
|
DR-XY46378
|
Atorvastatin + Perindopril (as arginine) + Amlodipine
|
Triveram Initio
|
10mg/ 5mg/ 5mg
|
Film-Coated Tablet
|
Antihypertensive/Anti-CAD/Antihyperlipidemic
|
Les Laboratoires Servier Industrie
|
France
|
Monitored Release
|
02 December 2019
|
11 June 2025
|
| View |
|
DR-XY46379
|
Ceftriaxone
|
Fretriaxone
|
1g
|
Powder For Injection Im/Iv
|
Antibacterial (Cephalosphorin)
|
Labesfal - Laboratorios Almiro S.A.
|
Portugal
|
Automatic Renewal
|
05 May 2023
|
18 June 2028
|
| View |
|
DR-XY46381
|
Diclofenac sodium
|
Acuflam
|
10 mg/g (1% w/w)
|
Topical Spray
|
Non-Steroidal Anti-Inflammatory
|
Unison Laboratories Co., Ltd.
|
Thailand
|
Automatic Renewal
|
05 July 2023
|
20 August 2028
|
| View |
|
DR-XY46384
|
Gemcitabine (As Hydrochloride)
|
Zytogem
|
200mg
|
Lyophilized Powder For IV Infusion
|
-
|
Ildong Pharmaceutical Co., Ltd.
|
Korea
|
Initial
|
24 May 2022
|
25 June 2025
|
| View |
|
DR-XY46385
|
Gemcitabine (As Hydrochloride)
|
Zytogem
|
1g
|
Lyophilized Powder for IV Infusion
|
-
|
Ildong Pharmaceutical Co., Ltd.
|
Korea
|
Initial
|
21 May 2021
|
25 June 2025
|
| View |
|
DR-XY46386
|
Meropenem (as Trihydrate)
|
Merovex 500
|
500 mg
|
Powder for Injection (IV)
|
Antibacterial (Carbapenem)
|
Venus Remedies Limited.
|
India
|
Renewal
|
08 May 2024
|
26 June 2028
|
| View |
|
DR-XY46387
|
Meropenem
|
Merovex 1000
|
1g
|
Powder For Injection
|
Antibacterials (Carbapenems)
|
Venus Remedies Limited
|
India
|
Automatic Renewal
|
21 July 2023
|
26 June 2028
|
| View |
|
DR-XY4639
|
Inosine Dimepranol Acedoben
|
Immunosin
|
250 mg/5 mL
|
Syrup
|
-
|
Amherst Laboratories, Inc.
|
Philippines
|
-
|
10 September 2021
|
25 November 2025
|
| View |
|
DR-XY46390
|
Imipenem + Cilastatin
|
VEXPINEM 500
|
500 mg + 500 mg
|
Powder For Injection
|
Antibacterials (Carbapenems)
|
Venus Remedies Limited
|
India
|
Automatic Renewal
|
21 July 2023
|
26 June 2028
|
| View |
|
DR-XY46394
|
Medroxyprogesterone Acetate
|
Famy-Depo
|
150 mg/mL
|
Suspension For Injection (IM)
|
-
|
Mylan Laboratories Ltd.
|
India
|
-
|
17 March 2022
|
09 July 2025
|
| View |
|
DR-XY46395
|
Desogestrel + Ethinylestradiol
|
Daisy-30
|
150 mcg/30 mcg
|
Tablet
|
-
|
Mylan Laboratories Ltd.
|
India
|
-
|
26 August 2020
|
09 July 2025
|